1. Short title This Act may be cited as the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019 . 2. Extended months of coverage of immunosuppressive drugs for kidney transplant patients and other renal dialysis provisions (a) Medicare entitlement to immunosuppressive drugs for kidney transplant recipients (1) In general Section 226A(b)(2) of the Social Security Act ( 42 U.S.C. 426–1(b)(2) ) is amended by inserting (except for eligibility for enrollment under part B solely for purposes of coverage of immunosuppressive drugs described in section 1861(s)(2)(J)) before , with the thirty-sixth month . (2) Individuals eligible only for coverage of immunosuppressive drugs (A) In general Section 1836 of the Social Security Act ( 42 U.S.C. 1395o ) is amended— (i) by striking Every and inserting (a) In general.— Every ; and (ii) by adding at the end the following new subsection: (b) Individuals eligible for immunosuppressive drug coverage (1) In general Except as provided under paragraph (2), every individual whose insurance benefits under part A have ended (whether before, on, or after January 1, 2022) by reason of section 226A(b)(2) is eligible to enroll in the insurance program established by this part solely for purposes of coverage of immunosuppressive drugs in accordance with section 1837(m). (2) Exception if other health insurance coverage is available (A) In general An individual described in paragraph (1) shall not be eligible for enrollment in the insurance program described in such paragraph with respect to any period in which the individual— (i) is enrolled in a group health plan, as defined in section 2791(a)(1) of the Public Health Service Act, or individual health insurance coverage, as defined in section 2791(b)(5) of such Act, as determined in accordance with subparagraph (B); (ii) is eligible for benefits under— (I) a State plan under title XIX; (II) a State child health plan under title XXI